Dynamic Visualization of Amyloid-β Plaques with a Novel NIR-II Fluorescence Reporter

Alzheimer's disease (AD), a progressive neurodegenerative disorder, represents a major global health challenge for aging populations. As amyloid-β (Aβ) plaques are pathological hallmarks of AD, their efficient detection is critical for disease staging and early diagnosis. However, existing fluorescent probes are hindered by a weak signal response to Aβ plaques, short-emission wavelengths, and insufficient blood-brain barrier (BBB) penetration, which preclude effective in vivo imaging. To address these limitations, we developed a novel series of second near-infrared window (NIR-II) probes, termed CoR-Aβs, engineered for high-affinity binding to Aβ fibrils. Demonstrating exceptional BBB permeability, our lead compound, CoR-Aβ-4, enables real-time dynamic tracking of plaque deposition in vivo. This work establishes NIR-II fluorescent probes as a transformative platform for advancing diagnostic strategies in neurodegenerative disease intervention.

Authors

Institutions

Publication Details

Journal
Analytical Chemistry
Published
2026-02-03
DOI
https://doi.org/10.1021/acs.analchem.5c07821
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dynamic Visualization of Amyloid-β Plaques with a Novel NIR-II Fluorescence Reporter

Xiaoqi Yu, Feifan XIANG, Dingheng Zhou, Heng Zhang et al.
Analytical Chemistry
Alzheimer's disease research and treatments
article

Dynamic Visualization of Amyloid-β Plaques with a Novel NIR-II Fluorescence Reporter

Xiaoqi Yu, Feifan XIANG, Dingheng Zhou, Heng Zhang, Shanyong Chen, Yuanyuan Zhang, Min Wu, Yang Yu, Qian Zhou, Kun Li
article en

Abstract

Alzheimer's disease (AD), a progressive neurodegenerative disorder, represents a major global health challenge for aging populations. As amyloid-β (Aβ) plaques are pathological hallmarks of AD, their efficient detection is critical for disease staging and early diagnosis. However, existing fluorescent probes are hindered by a weak signal response to Aβ plaques, short-emission wavelengths, and insufficient blood-brain barrier (BBB) penetration, which preclude effective in vivo imaging. To address these limitations, we developed a novel series of second near-infrared window (NIR-II) probes, termed CoR-Aβs, engineered for high-affinity binding to Aβ fibrils. Demonstrating exceptional BBB permeability, our lead compound, CoR-Aβ-4, enables real-time dynamic tracking of plaque deposition in vivo. This work establishes NIR-II fluorescent probes as a transformative platform for advancing diagnostic strategies in neurodegenerative disease intervention.

Analytical ChemistryVol. 98(6)
Xihua University (CN), Target (United States) (US), Sichuan University (CN), West China Hospital of Sichuan University (CN)
Good health and well-being
Openalex Percentile: Top 66%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.